Impact of systemic resveratrol on non-surgical periodontal treatment of smokers: A 12-month randomized clinical trial.
- 2025-08-30
- RCT · n = 19
- Clinical oral investigations 29(9)
- Vanessa Haguihara Lucchesi
- Ana Paula Oliveira Giorgetti
- Mônica Grazieli Corrêa
- Vanessa G A Pecorari
- Bruno Braga Benatti
- Howard C Tenenbaum
- Fabiano Ribeiro Cirano
- Suzana Peres Pimentel
- Márcio Zafallon Casati
- PubMed: 40884630
- DOI: 10.1007/s00784-025-06517-9
- High evidence
- Clinical
Immunoinflammatory analysis showed lower levels of IL-1β at 3-month periods in deep sites in the RSV group [92.6 ± 84.2; 35.36 (52.92) for PL and RSV, respectively] ... (p < 0.05).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 500 mg/day